Clinical trial
Efficacy of Sequential Denosumab After Teriparatide for 6 Months Compared With Denosumab Monotherapy in Reducing Risk of Osteoporotic Fractures in Patients With New Fractures: a Multicenter Randomized Controlled Trial (STAND Study)
NCT05866029 is registered in ClinicalTrials.gov with Peking Union Medical College Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Sequential Denosumab After Teriparatide for 6 Months Compared With Denosumab Monotherapy in Reducing Risk of Osteoporotic Fractures in Patients With New Fractures: a Multicenter Randomized Controlled Trial (STAND Study)
- Lead sponsor
- Peking Union Medical College Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- May 26, 2023
- Completion date
- September 30, 2026
- Enrollment
- 2,478 (estimated)
- Sites
- 58
Conditions
As the registry lists them; a condition with its own page is linked.